The Risk for New-Onset Diabetes Mellitus after Kidney Transplantation in Patients with Autosomal Dominant Polycystic Kidney Disease: A Systematic Review and Meta-Analysis

Canadian Journal of Diabetes

Volumn 40, Issue 6, 2016, Pages 521-528

  Cheungpasitporn, Wisit ^a   Thongprayoon, Charat ^a   Vijayvargiya, Priya ^a   Anthanont, Pimjai ^a,b   Erickson, Stephen B ^a  

^a MAYO CLINIC   (United States)

^b THAMMASAT UNIVERSITY   (Thailand)

Author keywords

autosomal dominant polycystic kidney disease (ADPKD); diabetes; graft; kidney; meta analysis; new onset diabetes; polycystic kidney; polycystic kidney diseases; transplantation

Indexed keywords

INSULIN;

ARTICLE; COHORT ANALYSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; FOLLOW UP; HUMAN; INSULIN TREATMENT; KIDNEY POLYCYSTIC DISEASE; KIDNEY TRANSPLANTATION; RISK ASSESSMENT; SYSTEMATIC REVIEW; ADVERSE EFFECTS; META ANALYSIS; ONSET AGE; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT; PROGNOSIS; RISK FACTOR;

AGE OF ONSET; DIABETES MELLITUS; HUMANS; KIDNEY TRANSPLANTATION; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT; PROGNOSIS; RISK FACTORS;

EID: 84966891710     PISSN: 14992671     EISSN: 23523840     Source Type: Journal    
DOI: 10.1016/j.jcjd.2016.03.001     Document Type: Article

References (34)

1. 1 Gonzalez-Posada, J.M., Hernandez, D., Genis, B.B., et al. Increased cardiovascular risk profile and mortality in kidney allograft recipients with post-transplant diabetes mellitus in Spain. Clin Transplant 20 (2006), 650–658.
2. 2 Cosio, F.G., Pesavento, T.E., Kim, S., et al. Patient survival after renal transplantation: IV. Impact of post-transplant diabetes. Kidney Int 62 (2002), 1440–1446.
3. 3 Kasiske, B.L., Snyder, J.J., Gilbertson, D., Matas, A.J., Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 3 (2003), 178–185.
4. 4 Miles, A.M., Sumrani, N., Horowitz, R., et al. Diabetes mellitus after renal transplantation: As deleterious as non-transplant-associated diabetes?. Transplantation 65 (1998), 380–384.
5. 5 Woodward, R.S., Schnitzler, M.A., Baty, J., et al. Incidence and cost of new-onset diabetes mellitus among U.S. wait-listed and transplanted renal allograft recipients. Am J Transplant 3 (2003), 590–598.
6. 6 Palepu, S., Prasad, G.V., New-onset diabetes mellitus after kidney transplantation: Current status and future directions. World J Diabetes 6 (2015), 445–455.
7. 7 Rakel, A., Karelis, A.D., New-onset diabetes after transplantation: Risk factors and clinical impact. Diabetes Metab 37 (2011), 1–14.
8. 8 Gunnarsson, R., Arner, P., Lundgren, G., et al. Diabetes mellitus: A more-common-than-believed complication of renal transplantation. Transplant Proc 11 (1979), 1280–1281.
9. 9 Heisel, O., Heisel, R., Balshaw, R., Keown, P., New-onset diabetes mellitus in patients receiving calcineurin inhibitors: A systematic review and meta-analysis. Am J Transplant 4 (2004), 583–595.
10. 10 Cosio, F.G., Pesavento, T.E., Osei, K., et al. Post-transplant diabetes mellitus: Increasing incidence in renal allograft recipients transplanted in recent years. Kidney Int 59 (2001), 732–737.
11. 11 Brunelli, S.M., Blanchette, C.M., Claxton, A.J., et al. End-stage renal disease in autosomal dominant polycystic kidney disease: A comparison of dialysis-related utilization and costs with other chronic kidney diseases. Clinicoecon Outcomes Res 7 (2015), 65–72.
12. 12 Kanaan, N., Devuyst, O., Pirson, Y., Renal transplantation in autosomal dominant polycystic kidney disease. Nat Rev Nephrol 10 (2014), 455–465.
13. 13 Chapman, A.B., Devuyst, O., Eckardt, K.U., et al. Autosomal-dominant polycystic kidney disease (ADPKD): Executive summary from a kidney disease: Improving global outcomes (KDIGO) controversies conference. Kidney Int 88 (2015), 17–27.
14. 14 Spithoven, E.M., Kramer, A., Meijer, E., et al. Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe: Prevalence and survival: An analysis of data from the ERA-EDTA registry. Nephrol Dial Transplant 29:Suppl. 4 (2014), iv15–25.
15. 15 Razeghi, E., Heydarian, P., Amerian, M., Pourmand, G., The risk factors for diabetes mellitus after kidney transplantation. Saudi J Kidney Dis Transpl 21 (2010), 1038–1043.
16. 16 Prakash, J., Rathore, S.S., Singh, T.B., Choudhury, T.A., New-onset diabetes after transplantation (NODAT): Analysis of pre-transplant risk factors in renal allograft recipients. Indian J Transplant 6 (2012), 77–82.
17. 17 Gentil, M.A., Luna, E., Rodriguez-Algarra, G., et al. Incidence of diabetes mellitus requiring insulin treatment after renal transplantation in patients with hepatitis C. Nephrol Dial Transplant 17 (2002), 887–891.
18. 18 de Mattos, A.M., Olyaei, A.J., Prather, J.C., et al. Autosomal-dominant polycystic kidney disease as a risk factor for diabetes mellitus following renal transplantation. Kidney Int 67 (2005), 714–720.
19. 19 Hamer, R.A., Chow, C.L., Ong, A.C., McKane, W.S., Polycystic kidney disease is a risk factor for new-onset diabetes after transplantation. Transplantation 83 (2007), 36–40.
20. 20 Goncalves, S., Guerra, J., Santana, A., et al. Autosomal-dominant polycystic kidney disease and kidney transplantation: Experience of a single center. Transplant Proc 41 (2009), 887–890.
21. 21 Caillard, S., Eprinchard, L., Perrin, P., et al. Incidence and risk factors of glucose metabolism disorders in kidney transplant recipients: Role of systematic screening by oral glucose tolerance test. Transplantation 91 (2011), 757–764.
22. 22 Jacquet, A., Pallet, N., Kessler, M., et al. Outcomes of renal transplantation in patients with autosomal dominant polycystic kidney disease: A nationwide longitudinal study. Transpl Int 24 (2011), 582–587.
23. 23 Vincenti, F., Friman, S., Scheuermann, E., et al. Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus. Am J Transplant 7 (2007), 1506–1514.
24. 24 Ducloux, D., Motte, G., Vautrin, P., et al. Polycystic kidney disease as a risk factor for post-transplant diabetes mellitus. Nephrol Dial Transplant 14 (1999), 1244–1246.
25. 25 Jadad, A.R., Moore, R.A., Carroll, D., et al. Assessing the quality of reports of randomized clinical trials: Is blinding necessary?. Control Clin Trials 17 (1996), 1–12.
26. 26 Stang, A., Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25 (2010), 603–605.
27. 27 DerSimonian, R., Laird, N., Meta-analysis in clinical trials. Control Clin Trials 7 (1986), 177–188.
28. 28 Higgins, J.P., Thompson, S.G., Deeks, J.J., Altman, D.G., Measuring inconsistency in meta-analyses. BMJ 327 (2003), 557–560.
29. 29 Easterbrook, P.J., Berlin, J.A., Gopalan, R., Matthews, D.R., Publication bias in clinical research. Lancet 337 (1991), 867–872.
30. 30 Ruderman, I., Masterson, R., Yates, C., et al. New-onset diabetes after kidney transplantation in autosomal dominant polycystic kidney disease: A retrospective cohort study. Nephrology (Carlton) 17 (2012), 89–96.
31. 31 Pietrzak-Nowacka, M., Safranow, K., Rozanski, J., et al. Autosomal dominant polycystic kidney disease is not a risk factor for post-transplant diabetes mellitus: Matched-pair design multicenter study. Arch Med Res 39 (2008), 312–319.
32. 32 Courivaud, C., Ladriere, M., Toupance, O., et al. Impact of pre-transplant dialysis modality on post-transplant diabetes mellitus after kidney transplantation. Clin Transplant 25 (2011), 794–799.
33. 33 Vareesangthip, K., Tong, P., Wilkinson, R., Thomas, T.H., Insulin resistance in adult polycystic kidney disease. Kidney Int 52 (1997), 503–508.
34. 34 Carter, S.A., Kitching, A.R., Johnstone, L.M., Four pediatric patients with autosomal recessive polycystic kidney disease developed new-onset diabetes after renal transplantation. Pediatr Transplant 18 (2014), 698–705.